Serotonin neuron loss and nonmotor symptoms continue in Parkinson's patients treated with dopamine grafts.
about
Clinical imaging in regenerative medicineStem cell-based approach for the treatment of Parkinson's diseaseTreating Parkinson's disease in the 21st century: can stem cell transplantation compete?Neuroimaging of Parkinson's disease: Expanding views.Neuroimaging in Parkinson disease: from research setting to clinical practice.Recent imaging advances in neurology.Molecular imaging to track Parkinson's disease and atypical parkinsonisms: New imaging frontiers.Improving response inhibition systems in frontotemporal dementia with citalopram.Long-term health of dopaminergic neuron transplants in Parkinson's disease patients.Long-term clinical outcome of fetal cell transplantation for Parkinson disease: two case reports.Wake-active neurons across aging and neurodegeneration: a potential role for sleep disturbances in promoting disease.Therapeutic application of neural stem cells and adult neurogenesis for neurodegenerative disorders: regeneration and beyondMonoamine reuptake inhibitors in Parkinson's disease.Improving response inhibition in Parkinson's disease with atomoxetine.Ovarian steroids regulate gene expression related to DNA repair and neurodegenerative diseases in serotonin neurons of macaques.Ziram, a pesticide associated with increased risk for Parkinson's disease, differentially affects the presynaptic function of aminergic and glutamatergic nerve terminals at the Drosophila neuromuscular junction.Prospects for engineering neurons from local neocortical cell populations as cell-mediated therapy for neurological disordersTreating non-motor symptoms of Parkinson's disease with transplantation of stem cellsSerotonin2C Receptors and the Motor Control of Oral ActivitySelective serotonin reuptake inhibition modulates response inhibition in Parkinson's disease.Adaptation and sensitization to proteotoxic stress.Multiple controls exerted by 5-HT2C receptors upon basal ganglia function: from physiology to pathophysiology.Bioengineered stem cells in neural development and neurodegeneration researchDyskinesias in Parkinson's disease: views from positron emission tomography studies.Adult subventricular zone neural stem cells as a potential source of dopaminergic replacement neuronsDopamine receptor mapping with PET imaging in Parkinson's disease.Stem cell reprogramming: basic implications and future perspective for movement disorders.Molecular imaging of levodopa-induced dyskinesias.Clinical translation of stem cell transplantation in Parkinson's disease.Treatment of Parkinson's disease using cell transplantation.Depression, Anxiety and the Bladder.Pluripotent stem cells progressing to the clinic.Emotional manifestations of PD: Neurobiological basis.Microfluidic systems for stem cell-based neural tissue engineering.Serotonin transporter in Parkinson's disease: A meta-analysis of positron emission tomography studies.Non-human primate models of PD to test novel therapies.A brief perspective on neural cell therapy.Proceedings: cell therapies for Parkinson's disease from discovery to clinic.Depressive symptoms in Parkinson's disease are related to reduced [123I]FP-CIT binding in the caudate nucleus.Restorative Strategies in Movement Disorders: the Contribution of Imaging.
P2860
Q26851906-44E50F6B-6ED4-480B-9FE4-80D06FC38307Q27004330-6038CE62-FCFF-44D3-9280-D8F1C8A225C7Q27024152-669F0C87-7AA3-4587-99D2-E7700CEF38C4Q28387732-ED77D3EB-5D5B-4ED7-B5CB-E867C23CB022Q30868628-F375BECB-3048-4CB9-9A70-CEF2A8B19262Q30916063-36A7B700-DAF7-4CAC-ACFE-91695252AAD5Q31158920-A9F2C56D-1B90-4CE8-B7FA-B56479CF0C4FQ33625542-21B912A4-DF9E-4C09-B410-CC5AD38CEFB2Q33928831-7597F341-65C0-4610-931F-751AD071B075Q34530719-04476A22-48C5-4A93-B4B2-A30CE052F86DQ35014204-B2B36B84-2533-4F54-9916-ADFF0A0803E5Q35120721-79FE4876-BA3C-449C-9A02-5ADCCCDD9A32Q35165280-4049B95B-F8B8-4FFC-8C12-E997D75610D7Q35264006-6898A871-F742-4545-BCB7-03CDFA3BAD17Q35544686-E6B25AB7-ED29-46C9-8647-E67D38130301Q36396140-A4E90B51-9961-4547-9254-6AA34CD5450AQ36509272-F41F957D-E341-4761-9414-7832250E8BCBQ36790753-84EC1621-E835-43FF-BE48-444EFA695F42Q36798864-3FD364BB-5D52-4300-A9AE-CB7143FB514AQ37647815-C0510EC6-2A51-4D5E-93D2-DF748DA74DCCQ37651678-E02ACAE4-8046-48E6-8360-2655D84DFDEAQ38101499-3A1F91AC-59CD-47FC-BE3E-9414A55D8D74Q38104829-DDA4F925-09CE-4846-9782-013A48AA9617Q38182651-0FE65FF7-FC83-4E96-98BB-14FD8384E1D2Q38191589-D990199E-C8EA-4949-8A26-EC4500453078Q38195788-68767FAC-C929-4CA8-B7AB-3565A593BD57Q38302834-3D3E222B-ED3A-4AEF-83F2-C3D540FEB751Q38355582-96140292-9A63-4E0B-8A08-5D5BB0C27BB4Q38579206-10CB6D50-E6AF-4366-9B7C-31E722115E15Q38594913-77454E21-83EC-4366-837D-6F186216454FQ38668369-B619FA74-61F1-4354-86CE-763E3954E29AQ38747535-9A7D3940-A0F2-45CB-8A2E-7A7EB4337018Q38797335-132C78A1-5089-427F-B66A-A921D1624648Q38863798-C3717B42-A9ED-4F0E-B1B5-52E846624F0AQ39055550-AE4D52AA-7A85-4805-A74D-28D88CD3AFC3Q39229450-C8B3A065-FAD0-4F7C-B440-DF9CF6E0F787Q41549791-52F8FAF7-29D8-4352-8156-E42E0343C99CQ42545361-BE6BF31C-11A5-4B3B-BFA1-A027B63B2681Q43833622-A3F07B14-775E-4C1D-9CF0-C15DC85B5647Q46109283-D8904798-0EBA-42E7-8074-F409EFB832D7
P2860
Serotonin neuron loss and nonmotor symptoms continue in Parkinson's patients treated with dopamine grafts.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Serotonin neuron loss and nonm ...... treated with dopamine grafts.
@en
Serotonin neuron loss and nonm ...... treated with dopamine grafts.
@nl
type
label
Serotonin neuron loss and nonm ...... treated with dopamine grafts.
@en
Serotonin neuron loss and nonm ...... treated with dopamine grafts.
@nl
prefLabel
Serotonin neuron loss and nonm ...... treated with dopamine grafts.
@en
Serotonin neuron loss and nonm ...... treated with dopamine grafts.
@nl
P2093
P2860
P50
P921
P1476
Serotonin neuron loss and nonm ...... treated with dopamine grafts.
@en
P2093
Clare Loane
Marios Politis
Olle Lindvall
Paola Piccini
P2860
P304
P356
10.1126/SCITRANSLMED.3003391
P407
P577
2012-04-01T00:00:00Z